State WV
Clinical Trials in West Virginia
Recruiting clinical trials with at least one study location in West Virginia. Data updated daily from ClinicalTrials.gov.
Top Conditions in West Virginia
NCT04965675 Phase 3
Recruiting
A Study With Eptinezumab in Adolescents (12-17 Years) With Chronic Migraine
Condition
Chronic Migraine in Children
Enrollment
285 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT05633654 Phase 3
Recruiting
Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physic...
Condition
Triple Negative Breast Cancer
Enrollment
1,514 pts
Location
United States, Australia, France
Sponsor
Gilead Sciences
NCT06856577 Phase 3
Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants ...
Condition
Neovascular Age-Related Macular Degeneration (nAMD)
Enrollment
284 pts
Location
United States
Sponsor
Adverum Biotechnologies, Inc.
NCT06819891 Phase 3
Recruiting
A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (...
Condition
Moderately to Severely Active Crohns Disease
Enrollment
425 pts
Location
United States, Argentina, Australia
Sponsor
Hoffmann-La Roche
NCT06389136 Phase 3
Recruiting
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Der...
Condition
Atopic Dermatitis
Enrollment
200 pts
Location
United States, Canada, Colombia
Sponsor
AbbVie
NCT05430035 EARLY_Phase 1
Recruiting
Safety and Feasibility of HIPEC for High-Risk Gallbladder Adenocarcinoma
Condition
Gallbladder Adenocarcinoma
Enrollment
10 pts
Location
United States
Sponsor
West Virginia University
NCT06498635 Phase 3
Recruiting
Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After ...
Condition
Lung Non-Small Cell Carcinoma
Enrollment
306 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT03671889 N/A
Recruiting
ExAblate Blood-Brain Barrier (BBB) Disruption for the Treatment of Alzheimer's D...
Condition
Alzheimer Disease
Enrollment
50 pts
Location
United States
Sponsor
InSightec
NCT03907046 Phase 3
Recruiting
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Condition
Intracerebral Hemorrhage
Enrollment
700 pts
Location
United States
Sponsor
Yale University
NCT05174169 Phase 2, Phase 3
Recruiting
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Condition
Stage III Colon Cancer
Enrollment
1,912 pts
Location
United States, Canada, Puerto Rico
Sponsor
NRG Oncology
NCT05642572 Phase 2
Recruiting
Comparing Combinations of Targeted Drugs for Advanced Non-Small Cell Lung Cancer...
Condition
Recurrent Lung Non-Small Cell Carcinoma
Enrollment
66 pts
Location
United States
Sponsor
SWOG Cancer Research Network
NCT07061964 Phase 2
Recruiting
Combining Immunotherapy and Radiation Therapy to Help Patients Avoid Bladder Rem...
Condition
Muscle Invasive Bladder Urothelial Carcinoma
Enrollment
111 pts
Location
United States
Sponsor
National Cancer Institute (NCI
NCT05164172 Phase 3
Recruiting
A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chroni...
Condition
Migraine
Enrollment
600 pts
Location
United States, Argentina, Canada
Sponsor
H. Lundbeck A/S
NCT04166409 Phase 3
Recruiting
A Study of the Drugs Selumetinib vs. Carboplatin and Vincristine in Patients Wit...
Condition
Low Grade Astrocytoma
Enrollment
170 pts
Location
United States, Canada, Puerto Rico
Sponsor
National Cancer Institute (NCI
NCT06486428 N/A
Recruiting
Small Cell Lung Cancer Community Engagement to Eliminate Research Discepancies
Condition
Small-cell Lung Cancer
Enrollment
30 pts
Location
United States
Sponsor
Addario Lung Cancer Medical In
NCT04755764 N/A
Recruiting
Effect of Labetalol, Atenolol, and Nifedipine on Maternal Hemodynamics Measured ...
Condition
Systolic Hypertension
Enrollment
60 pts
Location
United States
Sponsor
Marshall University
NCT06651177 Phase 2
Recruiting
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Op...
Condition
Opioid Use Disorder
Enrollment
310 pts
Location
United States
Sponsor
T. John Winhusen, PhD
NCT06152575 Phase 3
Recruiting
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in P...
Condition
Multiple Myeloma
Enrollment
492 pts
Location
United States, Argentina, Australia
Sponsor
Pfizer
NCT03325855 N/A
Recruiting
Fecal Microbiota Transplant National Registry
Condition
Fecal Microbiota Transplantation
Enrollment
4,000 pts
Location
United States, Canada
Sponsor
American Gastroenterological A
NCT03747458 Phase 3
Recruiting
OPN-375 Efficacy and Safety in Adolescents With Bilateral Nasal Polyps
Condition
Bilateral Nasal Polyposis
Enrollment
72 pts
Location
United States, Argentina
Sponsor
Optinose US Inc.
NCT01719055 N/A
Recruiting
RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-T...
Condition
Pain
Enrollment
4,800 pts
Location
United States, Argentina, Australia
Sponsor
Boston Scientific Corporation
Page 2 of 2 — 46 trials total